{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:36:56Z","timestamp":1793317016602,"version":"4.5.0"},"reference-count":46,"publisher":"American Association for Cancer Research (AACR)","issue":"12","license":[{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"vor","delay-in-days":87,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273955"],"award-info":[{"award-number":["82273955"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017962","name":"Jiangsu Commission of Health","doi-asserted-by":"publisher","award":["K2023073"],"award-info":[{"award-number":["K2023073"]}],"id":[{"id":"10.13039\/100017962","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009156","name":"Nantong Municipal Science and Technology Bureau","doi-asserted-by":"publisher","award":["JC2023036"],"award-info":[{"award-number":["JC2023036"]}],"id":[{"id":"10.13039\/501100009156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009156","name":"Nantong Municipal Science and Technology Bureau","doi-asserted-by":"publisher","award":["MSZ2024053"],"award-info":[{"award-number":["MSZ2024053"]}],"id":[{"id":"10.13039\/501100009156","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,6,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>Hepatocellular carcinoma (HCC) frequently develops resistance to lenvatinib, a first-line tyrosine kinase inhibitor. Resistance arises from heterogeneous mechanisms involving metabolic reprogramming and mitochondrial adaptation, implicating regulators of these processes as potential therapeutic targets. In this study, we identified \u03b1\/\u03b2 hydrolase domain containing 6 (ABHD6) as a critical driver of lenvatinib resistance by perturbing mitochondrial dynamics. Ligand binding at the S148 catalytic site allosterically controlled a molecular switch between canonical enzymatic and noncanonical scaffolding functions of ABHD6, and the proresistance function was independent of catalysis but required an unoccupied catalytic site. In resistant HCC, the Warburg effect elevated lactate, leading to K245 lactylation of ABHD6. This modification triggered the mitochondrial translocation of ABHD6, in which it functioned as a scaffold that competitively bound the fission regulator mitochondrial fission 1 (FIS1) and displaced dynamin-related protein 1 (DRP1). Disruption of the fission machinery stabilized hyperfused mitochondria, thereby conferring lenvatinib resistance by suppressing drug-induced apoptosis and ROS generation. Both inhibiting lactate production and enforcing occupancy of the S148 site with substrates or a specific inhibitor blocked formation of the ABHD6\u2013FIS1 complex, reactivated mitochondrial fission, and restored lenvatinib sensitivity. This study identified a lactate-driven functional switch in ABHD6 and established that targeting this allosteric mechanism is an effective therapeutic strategy to overcome lenvatinib resistance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>Lactylated ABHD6 moonlights as a regulator of mitochondrial dynamics by sequestering FIS1 to drive lenvatinib resistance in hepatocellular carcinoma, which can be overcome by targeting ABHD6 to disrupt the non-canonical scaffolding function.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/0008-5472.can-25-4282","type":"journal-article","created":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T20:06:51Z","timestamp":1774037211000},"page":"2970-2989","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Lactylation Converts ABHD6 into a Mitochondrial Regulator That Drives Lenvatinib Resistance in Hepatocellular Carcinoma"],"prefix":"10.1158","volume":"86","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-5959-2380","authenticated-orcid":false,"given":"Yuening","family":"Sun","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/001rahr89","id-type":"ROR","asserted-by":"publisher"}],"name":"Affiliated Hospital of Nantong University 1 Department of Pharmacy, , Pharmacy School of Nantong University, Nantong, China."},{"id":[{"id":"https:\/\/ror.org\/02afcvw97","id-type":"ROR","asserted-by":"publisher"}],"name":"Nantong University 2 Department of oncology, School of Medicine, , Nantong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8188-6998","authenticated-orcid":false,"given":"Chengju","family":"Luo","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/001rahr89","id-type":"ROR","asserted-by":"publisher"}],"name":"Affiliated Hospital of Nantong University 1 Department of Pharmacy, , Pharmacy School of Nantong University, Nantong, China."},{"id":[{"id":"https:\/\/ror.org\/02afcvw97","id-type":"ROR","asserted-by":"publisher"}],"name":"Nantong University 2 Department of oncology, School of Medicine, , Nantong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-2129-3717","authenticated-orcid":false,"given":"Hui","family":"Yang","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/001rahr89","id-type":"ROR","asserted-by":"publisher"}],"name":"Affiliated Hospital of Nantong University 1 Department of Pharmacy, , Pharmacy School of Nantong University, Nantong, China."},{"name":"3Department of Pharmacy, Rugao People\u2019s Hospital, Rugao, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9925-6594","authenticated-orcid":false,"given":"Jiaxin","family":"Ye","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/001rahr89","id-type":"ROR","asserted-by":"publisher"}],"name":"Affiliated Hospital of Nantong University 1 Department of Pharmacy, , Pharmacy School of Nantong University, Nantong, China."},{"id":[{"id":"https:\/\/ror.org\/02afcvw97","id-type":"ROR","asserted-by":"publisher"}],"name":"Nantong University 2 Department of oncology, School of Medicine, , Nantong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2520-8532","authenticated-orcid":false,"given":"Fengliang","family":"Song","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/001rahr89","id-type":"ROR","asserted-by":"publisher"}],"name":"Affiliated Hospital of Nantong University 1 Department of Pharmacy, , Pharmacy School of Nantong University, Nantong, China."},{"id":[{"id":"https:\/\/ror.org\/02afcvw97","id-type":"ROR","asserted-by":"publisher"}],"name":"Nantong University 2 Department of oncology, School of Medicine, , Nantong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-3479-1531","authenticated-orcid":false,"given":"Quanhua","family":"Yi","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/001rahr89","id-type":"ROR","asserted-by":"publisher"}],"name":"Affiliated Hospital of Nantong University 1 Department of Pharmacy, , Pharmacy School of Nantong University, Nantong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-3418-8038","authenticated-orcid":false,"given":"Wenhao","family":"Zou","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/001rahr89","id-type":"ROR","asserted-by":"publisher"}],"name":"Affiliated Hospital of Nantong University 1 Department of Pharmacy, , Pharmacy School of Nantong University, Nantong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5281-0783","authenticated-orcid":false,"given":"Yan","family":"Huang","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/001rahr89","id-type":"ROR","asserted-by":"publisher"}],"name":"Affiliated Hospital of Nantong University 4 Department of General Surgery, , , Nantong, China."},{"id":[{"id":"https:\/\/ror.org\/02afcvw97","id-type":"ROR","asserted-by":"publisher"}],"name":"Nantong University 4 Department of General Surgery, , , Nantong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-3988-7583","authenticated-orcid":false,"given":"Xiangjun","family":"Fan","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/001rahr89","id-type":"ROR","asserted-by":"publisher"}],"name":"Affiliated Hospital of Nantong University 4 Department of General Surgery, , , Nantong, China."},{"id":[{"id":"https:\/\/ror.org\/02afcvw97","id-type":"ROR","asserted-by":"publisher"}],"name":"Nantong University 4 Department of General Surgery, , , Nantong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9769-1853","authenticated-orcid":false,"given":"Lei","family":"Wang","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/001rahr89","id-type":"ROR","asserted-by":"publisher"}],"name":"Affiliated Hospital of Nantong University 4 Department of General Surgery, , , Nantong, China."},{"id":[{"id":"https:\/\/ror.org\/02afcvw97","id-type":"ROR","asserted-by":"publisher"}],"name":"Nantong University 4 Department of General Surgery, , , Nantong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3434-8772","authenticated-orcid":false,"given":"Yanan","family":"Zhang","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/001rahr89","id-type":"ROR","asserted-by":"publisher"}],"name":"Affiliated Hospital of Nantong University 1 Department of Pharmacy, , Pharmacy School of Nantong University, Nantong, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-7512-2392","authenticated-orcid":false,"given":"Qian","family":"Ding","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03jqs2n27","id-type":"ROR","asserted-by":"publisher"}],"name":"Macau University of Science and Technology 5 State Key Laboratory of Quality Research in Chinese Medicine, School of Pharmacy, , Macau SAR, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7700-8041","authenticated-orcid":false,"given":"Yizhun","family":"Zhu","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03jqs2n27","id-type":"ROR","asserted-by":"publisher"}],"name":"Macau University of Science and Technology 5 State Key Laboratory of Quality Research in Chinese Medicine, School of Pharmacy, , Macau SAR, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3786-7690","authenticated-orcid":false,"given":"Zhiyuan","family":"Tang","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/001rahr89","id-type":"ROR","asserted-by":"publisher"}],"name":"Affiliated Hospital of Nantong University 1 Department of Pharmacy, , Pharmacy School of Nantong University, Nantong, China."},{"id":[{"id":"https:\/\/ror.org\/02afcvw97","id-type":"ROR","asserted-by":"publisher"}],"name":"Nantong University 2 Department of oncology, School of Medicine, , Nantong, China."},{"name":"6Key Laboratory of Drug Metabolism and Pharmacokinetics, State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2026,3,20]]},"reference":[{"key":"2026061503091186400_bib1","doi-asserted-by":"crossref","first-page":"102446","DOI":"10.1016\/j.jceh.2024.102446","article-title":"Global epidemiology of hepatocellular carcinoma","volume":"15","author":"Singh","year":"2025","journal-title":"J Clin Exp Hepatol"},{"key":"2026061503091186400_bib2","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/S0140-6736(18)30207-1","article-title":"Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial","volume":"391","author":"Kudo","year":"2018","journal-title":"Lancet"},{"key":"2026061503091186400_bib3","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1111\/liv.15953","article-title":"Lenvatinib in hepatocellular carcinoma: resistance mechanisms and strategies for improved efficacy","volume":"44","author":"Qin","year":"2024","journal-title":"Liver Int"},{"key":"2026061503091186400_bib4","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/s12276-025-01415-2","article-title":"Metabolic reprogramming in hepatocellular carcinoma: mechanisms and therapeutic implications","volume":"57","author":"Park","year":"2025","journal-title":"Exp Mol Med"},{"key":"2026061503091186400_bib5","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.3390\/cancers13112571","article-title":"Mitochondrial dynamics and liver cancer","volume":"13","author":"Hern\u00e1ndez-Alvarez","year":"2021","journal-title":"Cancers (Basel)"},{"key":"2026061503091186400_bib6","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s10555-025-10251-9","article-title":"Mitochondrial alterations and signatures in hepatocellular carcinoma","volume":"44","author":"Chen","year":"2025","journal-title":"Cancer Metastasis Rev"},{"key":"2026061503091186400_bib7","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.3390\/cells10081901","article-title":"Mitochondrial metabolic signatures in hepatocellular carcinoma","volume":"10","author":"Lee","year":"2021","journal-title":"Cells"},{"key":"2026061503091186400_bib8","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.tips.2019.02.002","article-title":"ABHD6: its place in endocannabinoid signaling and beyond","volume":"40","author":"Cao","year":"2019","journal-title":"Trends Pharmacol Sci"},{"key":"2026061503091186400_bib9","doi-asserted-by":"crossref","first-page":"29869","DOI":"10.1074\/jbc.M115.669168","article-title":"\u03b1\/\u03b2 hydrolase domain-containing 6 (ABHD6) degrades the late endosomal\/lysosomal lipid bis(monoacylglycero)phosphate","volume":"290","author":"Pribasnig","year":"2015","journal-title":"J Biol Chem"},{"key":"2026061503091186400_bib10","doi-asserted-by":"crossref","first-page":"108157","DOI":"10.1016\/j.jbc.2025.108157","article-title":"Identification of ABHD6 as a lysophosphatidylserine lipase in the mammalian liver and kidneys","volume":"301","author":"Chakraborty","year":"2025","journal-title":"J Biol Chem"},{"issue":"Suppl 1","key":"2026061503091186400_bib11","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/dom.13008","article-title":"Monoacylglycerol signalling and ABHD6 in health and disease","volume":"19","author":"Poursharifi","year":"2017","journal-title":"Diabetes Obes Metab"},{"key":"2026061503091186400_bib12","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.celrep.2013.08.047","article-title":"The serine hydrolase ABHD6 is a critical regulator of the metabolic syndrome","volume":"5","author":"Thomas","year":"2013","journal-title":"Cell Rep"},{"key":"2026061503091186400_bib13","doi-asserted-by":"crossref","first-page":"102696","DOI":"10.1016\/j.ebiom.2020.102696","article-title":"Enhanced monoacylglycerol lipolysis by ABHD6 promotes NSCLC pathogenesis","volume":"53","author":"Tang","year":"2020","journal-title":"EBioMedicine"},{"key":"2026061503091186400_bib14","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/mc.23678","article-title":"ABHD6 suppresses colorectal cancer progression via AKT signaling pathway","volume":"63","author":"Xiong","year":"2024","journal-title":"Mol Carcinog"},{"key":"2026061503091186400_bib15","doi-asserted-by":"crossref","first-page":"102768","DOI":"10.1016\/j.sbi.2023.102768","article-title":"Protein dynamics underlying allosteric regulation","volume":"84","author":"Astore","year":"2024","journal-title":"Curr Opin Struct Biol"},{"key":"2026061503091186400_bib16","doi-asserted-by":"crossref","first-page":"e174587","DOI":"10.1172\/JCI174587","article-title":"The alanyl-tRNA synthetase AARS1 moonlights as a lactyltransferase to promote YAP signaling in gastric cancer","volume":"134","author":"Ju","year":"2024","journal-title":"J Clin Invest"},{"key":"2026061503091186400_bib17","doi-asserted-by":"crossref","first-page":"e80140","DOI":"10.7554\/eLife.80140","article-title":"Ligand-induced shifts in conformational ensembles that describe transcriptional activation","volume":"11","author":"Khan","year":"2022","journal-title":"Elife"},{"key":"2026061503091186400_bib18","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1136\/gutjnl-2024-334361","article-title":"Histone lactylation-driven feedback loop modulates cholesterol-linked immunosuppression in pancreatic cancer","volume":"74","author":"Yang","year":"2025","journal-title":"Gut"},{"key":"2026061503091186400_bib19","doi-asserted-by":"crossref","first-page":"1513047","DOI":"10.3389\/fimmu.2024.1513047","article-title":"Lactate-induced protein lactylation in cancer: functions, biomarkers and immunotherapy strategies","volume":"15","author":"Wang","year":"2024","journal-title":"Front Immunol"},{"key":"2026061503091186400_bib20","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s40164-025-00622-x","article-title":"Lactylation modification in cancer: mechanisms, functions, and therapeutic strategies","volume":"14","author":"Lv","year":"2025","journal-title":"Exp Hematol Oncol"},{"key":"2026061503091186400_bib21","doi-asserted-by":"crossref","first-page":"14049","DOI":"10.1038\/ncomms14049","article-title":"Massively parallel digital transcriptional profiling of single cells","volume":"8","author":"Zheng","year":"2017","journal-title":"Nat Commun"},{"key":"2026061503091186400_bib22","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","article-title":"Integrated analysis of multimodal single-cell data","volume":"184","author":"Hao","year":"2021","journal-title":"Cell"},{"key":"2026061503091186400_bib23","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","article-title":"Fast, sensitive and accurate integration of single-cell data with Harmony","volume":"16","author":"Korsunsky","year":"2019","journal-title":"Nat Methods"},{"key":"2026061503091186400_bib24","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1038\/nmeth.4463","article-title":"SCENIC: single-cell regulatory network inference and clustering","volume":"14","author":"Aibar","year":"2017","journal-title":"Nat Methods"},{"key":"2026061503091186400_bib25","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/nmeth.4402","article-title":"Reversed graph embedding resolves complex single-cell trajectories","volume":"14","author":"Qiu","year":"2017","journal-title":"Nat Methods"},{"key":"2026061503091186400_bib26","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.3390\/molecules29092155","article-title":"Untargeted metabolomics based on ultra-high-performance liquid chromatography coupled with quadrupole orbitrap high-resolution mass spectrometry for differential metabolite analysis of pinelliae rhizoma and its adulterants","volume":"29","author":"Wang","year":"2024","journal-title":"Molecules"},{"key":"2026061503091186400_bib27","doi-asserted-by":"crossref","first-page":"17309","DOI":"10.1021\/acs.analchem.5c01213","article-title":"mzrtsim: Raw data simulation for reproducible gas\/liquid chromatography-mass spectrometry-based nontargeted metabolomics data analysis","volume":"97","author":"Yu","year":"2025","journal-title":"Anal Chem"},{"key":"2026061503091186400_bib28","doi-asserted-by":"crossref","first-page":"W398","DOI":"10.1093\/nar\/gkae253","article-title":"MetaboAnalyst 6.0: towards a unified platform for metabolomics data processing, analysis and interpretation","volume":"52","author":"Pang","year":"2024","journal-title":"Nucleic Acids Res"},{"key":"2026061503091186400_bib29","doi-asserted-by":"crossref","first-page":"4313","DOI":"10.1093\/bioinformatics\/bty528","article-title":"MetaboAnalystR: an R package for flexible and reproducible analysis of metabolomics data","volume":"34","author":"Chong","year":"2018","journal-title":"Bioinformatics"},{"key":"2026061503091186400_bib30","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1186\/s12859-022-05005-1","article-title":"Single sample pathway analysis in metabolomics: performance evaluation and application","volume":"23","author":"Wieder","year":"2022","journal-title":"BMC Bioinformatics"},{"key":"2026061503091186400_bib31","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s12967-022-03317-7","article-title":"Lenvatinib inhibits the growth of gastric cancer patient-derived xenografts generated from a heterogeneous population","volume":"20","author":"Karalis","year":"2022","journal-title":"J Transl Med"},{"key":"2026061503091186400_bib32","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.apsb.2023.09.015","article-title":"A multidimensional platform of patient-derived tumors identifies drug susceptibilities for clinical lenvatinib resistance","volume":"14","author":"Sun","year":"2024","journal-title":"Acta Pharm Sin B"},{"key":"2026061503091186400_bib33","doi-asserted-by":"crossref","first-page":"101059","DOI":"10.1016\/j.drup.2024.101059","article-title":"Single-cell transcriptome analysis reveals the association between histone lactylation and cisplatin resistance in bladder cancer","volume":"73","author":"Li","year":"2024","journal-title":"Drug Resist Updat"},{"key":"2026061503091186400_bib34","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1038\/s41598-018-36633-4","article-title":"Biochemical and proteomic characterization of recombinant human \u03b1\/\u03b2 hydrolase domain 6","volume":"9","author":"Shields","year":"2019","journal-title":"Sci Rep"},{"key":"2026061503091186400_bib35","doi-asserted-by":"crossref","first-page":"660095","DOI":"10.3389\/fendo.2021.660095","article-title":"Mitochondrial fission protein 1: emerging roles in organellar form and function in health and disease","volume":"12","author":"Ihenacho","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2026061503091186400_bib36","doi-asserted-by":"crossref","first-page":"216405","DOI":"10.1016\/j.canlet.2023.216405","article-title":"Targeting LINC01607 sensitizes hepatocellular carcinoma to Lenvatinib via suppressing mitophagy","volume":"576","author":"Zhang","year":"2023","journal-title":"Cancer Lett"},{"key":"2026061503091186400_bib37","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/s41586-021-03510-6","article-title":"Distinct fission signatures predict mitochondrial degradation or biogenesis","volume":"593","author":"Kleele","year":"2021","journal-title":"Nature"},{"key":"2026061503091186400_bib38","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3390\/ph14010036","article-title":"Lenvatinib for hepatocellular carcinoma: a literature review","volume":"14","author":"Hatanaka","year":"2021","journal-title":"Pharmaceuticals (Basel)"},{"key":"2026061503091186400_bib39","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","article-title":"Hepatocellular carcinoma","volume":"7","author":"Llovet","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"2026061503091186400_bib40","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1126\/science.1219855","article-title":"Mitochondrial fission, fusion, and stress","volume":"337","author":"Youle","year":"2012","journal-title":"Science"},{"key":"2026061503091186400_bib41","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.cmet.2022.01.007","article-title":"The hallmarks of cancer metabolism: still emerging","volume":"34","author":"Pavlova","year":"2022","journal-title":"Cell Metab"},{"key":"2026061503091186400_bib42","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"2026061503091186400_bib43","doi-asserted-by":"crossref","first-page":"1535611","DOI":"10.3389\/fcell.2025.1535611","article-title":"Non-histone lactylation: unveiling its functional significance","volume":"13","author":"Shi","year":"2025","journal-title":"Front Cell Dev Biol"},{"key":"2026061503091186400_bib44","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/s42255-022-00710-w","article-title":"Lactylome analysis suggests lactylation-dependent mechanisms of metabolic adaptation in hepatocellular carcinoma","volume":"5","author":"Yang","year":"2023","journal-title":"Nat Metab"},{"key":"2026061503091186400_bib45","doi-asserted-by":"crossref","first-page":"101248","DOI":"10.1016\/j.drup.2025.101248","article-title":"Lactylation in cancer progression and drug resistance","volume":"81","author":"Sun","year":"2025","journal-title":"Drug Resist Updat"},{"key":"2026061503091186400_bib46","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/s41586-019-1730-1","article-title":"A view on drug resistance in cancer","volume":"575","author":"Vasan","year":"2019","journal-title":"Nature"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/doi\/10.1158\/0008-5472.CAN-25-4282\/3750045\/can-25-4282.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/doi\/10.1158\/0008-5472.CAN-25-4282\/3795016\/can-25-4282.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/86\/12\/2970\/3801046\/can-25-4282.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/86\/12\/2970\/3801046\/can-25-4282.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T07:09:28Z","timestamp":1781507368000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/86\/12\/2970\/785627\/Lactylation-Converts-ABHD6-into-a-Mitochondrial"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,20]]},"references-count":46,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2026,3,20]]},"published-print":{"date-parts":[[2026,6,15]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-25-4282","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/0008-5472.32675004","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.32674992","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.32674980","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.32675001","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.32674998","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.32674986","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.32675007","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.32674995","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.32674983","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.c.8536758","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,20]]}}}